Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine for Primary Nocturnal Enuresis in Children With ADHD
NCT06841666Phase 1Not yet recruiting
- Sponsor
- Tanta University
- Start
- Feb 2025
- Primary completion
- Aug 2025
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial in nocturnal enuresis (NE) comparing Atomoxetine Arm with Placebo Arm (2 arms). Primary endpoint: Frequency of nocturnal enuresis episodes at 6 months. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
atomoxetine
03
Conditions
nocturnal enuresis (NE)
Beyond the preview
Go deeper on NCT06841666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06841666.